UNSPSC 51141549: Beclamide

This classification denotes an anticonvulsant agent with the molecular formula C10H12ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F5N0ALI65V, chemically known as propionamide, n-benzyl-3-chloro- but generally known as beclamide, which bears US NIH Compound Identifier 10391. European Medicines Agency schedules Beclamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05675MIG.

UNSPSC 51141549 Beclamide (Commodity) does not reflect the work actually being solicited under this code in recent state and local procurement activity. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—seeks Naloxone and Safe Drug Deactivation Systems for community health initiatives, a scope unrelated to the Beclamide chemical classification. The code shows little relevant recent activity tied to its nominal pharmaceutical scope.

Seminole County's solicitation calls for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB, with a response deadline of July 26, 2023, requires bidders to submit unit costs electronically through the county's e-Procurement Portal, include all shipping and delivery costs in proposals, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify and drug-free workplace requirements. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary period. Potential FEMA funding introduces additional federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. Without a clearer pattern of Beclamide-specific solicitations, the code does not support a procurement pursuit strategy at this time.